ArticleCalcified tissue international2025
Bone Density, Microarchitecture, and Geometry Assessment in Patients with Pachydermoperiostosis Using Second-Generation High-Resolution Peripheral Quantitative Computed Tomography: A Case-Control Study.
Article in Calcified tissue international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pachydermoperiostosis (PDP) is a rare genetic disorder manifesting with periostosis, clubbing, and thickened skin. The impact of PDP on bone density and microarchitecture is underexplored despite the potential derangement in bone health due to systemic inflammation. This cross-sectional case-control study was conducted in a tertiary care center in north India from July 2022 to July 2023. We compared treatment naïve PDP patients (n = 8) with age and BMI-matched apparently healthy controls. All participants underwent clinical examination and estimation of biochemical parameters including calcium, phosphorus, alkaline phosphatase, 25(OH)D, and iPTH. Bone turnover markers C-terminal telopeptide of type I collagen (CTX) and procollagen type I N-propeptide (P1NP) were also assessed. All patients underwent areal and volumetric bone density measurements using dual-energy X-ray absorptiometry (DXA) and high-resolution peripheral quantitative computed tomography (HR-pQCT). HR-pQCT analysis revealed diminished cortical volumetric bone mineral density and altered microarchitecture in PDP patients at the radius and tibia, characterized by increased cortical porosity. Bone geometry assessment demonstrated increased cross-sectional bone area both in the cortical and trabecular compartments. Finite element analysis (FEA) indicated a substantial reduction in failure load, cortical and trabecular von Mises stress (VMS) at the tibia and stiffness at the radius in PDP patients compared to controls. PDP patients had similar biochemical and bone turnover parameters to controls. Individuals with PDP show reduced cortical vBMD with disrupted bone microarchitecture. These changes may reflect PGE2-mediated inflammation and bone resorption, suggesting increased fracture risk and the need for ongoing monitoring.
Indexed as
Identifiers
40886215What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.